Study finds hospital-diagnosed overweight or obesity linked with markedly higher risk of death over 40 years

September 02, 2020

Individuals whose overweight or obesity is diagnosed in hospital are 60% more likely to die compared to the general population, according to a nationwide Danish study that followed over 1.9 million people for up to 40 years, being presented at The European and International Congress on Obesity (ECOICO), held online this year from 1-4 September [1].

The risk of dying was highest within the first year of diagnosis, but remained markedly higher for individuals with hospital-diagnosed overweight or obesity over the whole study period.

Obesity is already known to be a strong risk factor for several chronic diseases such as type 2 diabetes, high blood pressure, and cardiovascular disease, that are linked to an increased death risk. However, long-term studies on mortality among people with hospital-diagnosed overweight and obesity are lacking.

In this study, researchers used population-based medical registries covering all Danish hospitals to identify all patients with a first hospital-based overweight or obesity diagnosis between 1979 and 2018. Each patient was matched with five individuals from the general population of the same age and sex to compare risk of death and mortality rates.

Over the 40-year period, there were 68,506 deaths among 322,130 individuals diagnosed with overweight or obesity, and 253,897 deaths among 1.6 million people in the matched Danish population. After adjusting for known risk factors including sex, age, income, education, and common comorbidities such as diabetes, cancer, and stroke, overall patients with overweight or obesity had a 60% higher risk of dying from any cause than their counterparts in the general population.

In the first year after diagnosis with overweight or obesity, the death rate was six times higher than the general population (2.5% vs 0.4%). Specifically, people with overweight or obesity were more than twice as likely to die from endocrine diseases, and had nearly double the risk of dying from cardiovascular diseases and gastrointestinal diseases.

However, the overall risk of death decreased over time--falling from a 55% higher risk of death in 1977-1989 to a 27% greater risk in 2010-2018. Even so, people with overweight or obesity were still 31% more likely to die from cancer than the general population over the whole study period, and almost twice as likely to die from respiratory diseases.

"While our large cohort study suggests survival has improved in patients with overweight and obesity over the last decade, they still face a considerably higher risk death than the general population, and much more needs to be done to prevent overweight and obesity", says Dr Sigrid Gribsholt from Aarhus University Hospital, Denmark, who led the research.

She continues, "Cardiovascular diseases and infections are some of the major causes of mortality in our study, and the decrease in overweight- and obesity-associated mortality may be due to better prevention and treatment of these diseases. It's also possible that more awareness of overweight and obesity, and greater use of overweight and obesity diagnosis codes, in recent years may partially explain why mortality fell over time."

The authors acknowledge that the findings show observational associations, so no conclusions can be drawn about cause and effect. They point to several limitations, including that they mortality risk among patients with overweight may be less pronounced than in those with obesity. They also note that because the prevalence of obesity has increased in the general population over the study period, the estimates may be more conservative than might have been seen in a normal-weight population.

European Association for the Study of Obesity

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal)

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to